Meeting Report From “Correlates of Protection for Next Generation Influenza Vaccines: Lessons Learned From the COVID-19 Pandemic”

IF 4.3 4区医学 Q1 INFECTIOUS DISEASES Influenza and Other Respiratory Viruses Pub Date : 2024-10-08 DOI:10.1111/irv.13314

Florian Krammer, Jacqueline M. Katz, Othmar G. Engelhardt, Diane J. Post, Paul C. Roberts, Sheena G. Sullivan, S. Mark Tompkins, Christopher Chiu, Stacey Schultz-Cherry, Rebecca Jane Cox

{"title":"Meeting Report From “Correlates of Protection for Next Generation Influenza Vaccines: Lessons Learned From the COVID-19 Pandemic”","authors":"Florian Krammer, Jacqueline M. Katz, Othmar G. Engelhardt, Diane J. Post, Paul C. Roberts, Sheena G. Sullivan, S. Mark Tompkins, Christopher Chiu, Stacey Schultz-Cherry, Rebecca Jane Cox","doi":"10.1111/irv.13314","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>This report summarizes the discussions and conclusions from the “Correlates of Protection for Next Generation Influenza Vaccines: Lessons Learned from the COVID-19 Pandemic” meeting, which took place in Seattle, USA, from March 1, 2023, to March 3, 2023.</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>Discussions around influenza virus correlates of protection and their use continued from where the discussion had been left off in 2019. While there was not much progress in the influenza field itself, many lessons learned during the coronavirus disease 2019 (COVID-19) pandemic, especially the importance of mucosal immunity, were discussed and can directly be applied to influenza correlates of protection.</p>\n </section>\n </div>","PeriodicalId":13544,"journal":{"name":"Influenza and Other Respiratory Viruses","volume":"18 10","pages":""},"PeriodicalIF":4.3000,"publicationDate":"2024-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11461279/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Influenza and Other Respiratory Viruses","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/irv.13314","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}

引用次数: 0

Abstract

Background

This report summarizes the discussions and conclusions from the “Correlates of Protection for Next Generation Influenza Vaccines: Lessons Learned from the COVID-19 Pandemic” meeting, which took place in Seattle, USA, from March 1, 2023, to March 3, 2023.

Conclusions

Discussions around influenza virus correlates of protection and their use continued from where the discussion had been left off in 2019. While there was not much progress in the influenza field itself, many lessons learned during the coronavirus disease 2019 (COVID-19) pandemic, especially the importance of mucosal immunity, were discussed and can directly be applied to influenza correlates of protection.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

从 COVID-19 大流行中汲取的经验教训 "会议报告：从 COVID-19 大流行中汲取的经验教训"。

背景：本报告总结了 2023 年 3 月 1 日至 2023 年 3 月 3 日在美国西雅图举行的 "下一代流感疫苗的保护相关性：从 COVID-19 大流行中汲取的经验教训 "会议的讨论和结论，会议于 2023 年 3 月 1 日至 2023 年 3 月 3 日在美国西雅图举行：围绕流感病毒相关保护及其使用的讨论在 2019 年中断的地方继续进行。虽然流感领域本身没有取得太大进展，但会议讨论了在 2019 年冠状病毒病（COVID-19）大流行期间吸取的许多经验教训，特别是粘膜免疫的重要性，这些经验教训可直接应用于流感病毒相关保护措施。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Influenza and Other Respiratory Viruses 医学-病毒学

CiteScore

7.20

自引率

4.50%

发文量

120

审稿时长

6-12 weeks

期刊介绍： Influenza and Other Respiratory Viruses is the official journal of the International Society of Influenza and Other Respiratory Virus Diseases - an independent scientific professional society - dedicated to promoting the prevention, detection, treatment, and control of influenza and other respiratory virus diseases. Influenza and Other Respiratory Viruses is an Open Access journal. Copyright on any research article published by Influenza and Other Respiratory Viruses is retained by the author(s). Authors grant Wiley a license to publish the article and identify itself as the original publisher. Authors also grant any third party the right to use the article freely as long as its integrity is maintained and its original authors, citation details and publisher are identified.